Publications (23) MARIA ANGELES SOLINIS ASPIAZU publications

filter_list Biomedical Engineering

2024

  1. Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells

    Journal of Drug Delivery Science and Technology, Vol. 99

2022

  1. Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease

    Nanomaterials, Vol. 12, Núm. 14

2021

  1. Functionalised SLNs-based nanovectors for gene therapy in Fabry disease: The liver as an α-Galactosidase A factory

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 46-48

  2. Mrna-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation

    Pharmaceutics, Vol. 13, Núm. 9

2019

  1. MMP-9 downregulation with lipid nanoparticles for inhibiting corneal neovascularization by gene silencing

    Nanomaterials, Vol. 9, Núm. 4

2016

  1. Application of lipid nanoparticles to ocular drug delivery

    Expert Opinion on Drug Delivery, Vol. 13, Núm. 12, pp. 1743-1757

  2. Applications of lipid nanoparticles in gene therapy

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 109, pp. 184-193

2015

  1. Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference

    International Journal of Pharmaceutics, Vol. 479, Núm. 1, pp. 181-188

2014

  1. A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases

    International Journal of Pharmaceutics, Vol. 465, Núm. 1-2, pp. 413-426

  2. Fate of nanostructured lipid carriers (NLCs) following the oral route: Design, pharmacokinetics and biodistribution

    Journal of Microencapsulation, Vol. 31, Núm. 1, pp. 1-8

2013

  1. Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: Influence of technological factors

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 84, Núm. 2, pp. 309-314

  2. Lipid nanoparticles as drug/gene delivery systems to the retina

    Journal of Ocular Pharmacology and Therapeutics, Vol. 29, Núm. 2, pp. 173-188

  3. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier

    Journal of Controlled Release, Vol. 166, Núm. 2, pp. 115-123

  4. New gene delivery system based on oligochitosan and solid lipid nanoparticles: 'In vitro' and 'in vivo' evaluation

    European Journal of Pharmaceutical Sciences, Vol. 50, Núm. 3-4, pp. 484-491

  5. Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors

    Journal of Gene Medicine, Vol. 15, Núm. 11-12, pp. 427-440

2012

  1. Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis

    Human Gene Therapy, Vol. 23, Núm. 4, pp. 345-355

  2. Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice

    International Journal of Pharmaceutics, Vol. 425, Núm. 1-2, pp. 35-43

  3. Multicomponent nanoparticles as nonviral vectors for the treatment of fabry disease by gene therapy

    Drug Design, Development and Therapy, Vol. 6, pp. 303-310

2011

  1. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Núm. 3, pp. 495-502

2010

  1. Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration

    International Journal of Pharmaceutics, Vol. 385, Núm. 1-2, pp. 157-162